Get in touch
Helping oncologists and patients defeat cancer with the right therapy
Mask for Genomate HealthGenomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
Welcome to
Genomate Health
the company behind world's first AI-powered clinical decision support system for precision oncology. We are a team of experienced professionals in oncology, AI, and business dedicated to revolutionizing cancer treatment by providing personalized care to every patient. We are a spin-out and partner company of Oncompass Medicine, located in Budapest, Hungary.

We are proud to have transformed the lives of countless cancer patients, providing hope and better outcomes. Genomate can help predict patients who are not likely to benefit from a drug and should get another treatment.
Our story
Genomate Health was founded with a clear vision: to revolutionize cancer treatment through personalized medicine. Our journey began with a passionate team of doctors and scientists who recognized the need for innovative solutions in oncology.

We embarked on a comprehensive research and development journey that spanned several decades. Our dedicated team worked tirelessly to refine our AI algorithms and create the Genomate platform, laying the foundation for a new era in cancer care.
Mask for Genomate HealthAbstract picture of cancer tumour by Genomate Health
2003
2015
2019
2021
2022
2023
2024
Founding of Oncompass Medicine Hungary Kft
Oncompass was founded in 2003 by two physicians, Istvan Petak and Richard Schwab, with a special background in molecular pharmacology and pathology
First successful personalized treatment
First successful personalized treatment with targeted therapy of a lung cancer patient the world published in Journal of Clinical Oncology in the US.
Registration and utilization of the first AI tool for precision oncology
Breakthrough Innovations (AI) in Oncology Conference Award at ASCO 2019
Future Unicorn Award of the DIGITALEUROPE and the EU Commission for the most promising European technology company.
Global Champion of the GET-IN-THE-RING global startup competition out of 25,000 applicants of 109 countries, from all fields and industries.
Landmark publication in Nature’s NPJ Precision Oncology
introducing the first clinically proven AI tool for personalized treatment decisions in precision medicine.
Incorporation of Genomate Health and launch of Genomate
Genomate Health is a founding member of CancerX
White House initiative, to empower oncologists with technology in the battle against cancer
Genomate Health Graduates from Mayo Clinic Platform_Accelerate
We have received prestigious awards and accolades for our innovative approach and dedication to advancing precision oncology.

Future Unicorn Award: Most promising
technology company in Europe

DIGITALEUROPE,
2021 edition

Breakthrough Innovations (AI) in Oncology Conference Award 2019

AMERICAN SOCIETY OF
CLINICAL ONCOLOGY
AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Global Champion
109 countries, 25,000 applicants

GET IN THE RINGSTART-UP
COMPETITION IN 2021
Our Vision & Values
Mask for Genomate Health
Our vision
A world where every patient receives the right treatment. The first time. Everytime.
Mask for Genomate Health
We’re pioneers
We lead the way into a world where every patient has the right treatment.
Mask for Genomate Health
We’re modern craftsmen
Everything we build is based on multidisciplinary expertise.
Mask for Genomate Health
We’re reliable
Everything we do is backed by years of scientific research.
Mask for Genomate Health
We’re quality-driven
Our scientific methods, professionalism and ethics cannot be questioned.
US-based. Helping the world.
We are actively expanding our reach to collaborate with healthcare providers and oncologists worldwide, ensuring that patients can benefit from the transformative power of Genomate.
Genomate - the world’s first AI-powered clinical decision support that matches targeted therapies to the totality of available molecular information for each patient
Join us in revolutionizing personalized
cancer treatment with AI.
Speak with an Expert